Scheffer Tseng
51Patents
16h-index
19Co-inventors
81Inventor score
Filing activity: Apr 29, 1994 → Jun 10, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6326019A | Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries | Human Necessities | 202 | Expired |
| US6152142A | Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries | Human Necessities | 184 | Expired |
| US6153607A | Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance (or turnover) | Human Necessities | 141 | Expired |
| US8153162B2 | Purified amniotic membrane compositions and methods of use | Human Necessities | 94 | Active |
| US6438398B1 | Process and device for measuring tear fluorescein clearance | Physics | 73 | Expired |
| US8182841B2 | Amniotic membrane preparations and purified compositions and anti-inflammation methods | Human Necessities | 65 | Active |
| US8182840B2 | Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition | Human Necessities | 63 | Active |
| US8187639B2 | Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment | Human Necessities | 61 | Active |
| US7494802B2 | Amniotic membrane covering for a tissue surface and devices facilitating fastening of membranes | Human Necessities | 60 | Expired |
| US7121666B2 | Apparatus and method for the kinetic analysis of tear stability | Human Necessities | 51 | Expired |
| US7824671B2 | Retinal pigment epithelial cell cultures on amniotic membrane and transplantation | Chemistry; Metallurgy | 45 | Expired |
| US8460714B2 | Purified amniotic membrane compositions and methods of use | Human Necessities | 39 | Active |
| US8440235B2 | Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition | Human Necessities | 38 | Active |
| US8455009B2 | Amniotic membrane preparations and purified compositions and anti-inflammation methods | Human Necessities | 37 | Active |
| US8420126B2 | Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment | Human Necessities | 36 | Active |
| US8128968B2 | Compositions and methods for treating Demodex infestations | Human Necessities | 16 | Active |
| US9161955B2 | Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition | Human Necessities | 16 | Active |
| US9198939B2 | Purified amniotic membrane compositions and methods of use | Human Necessities | 16 | Active |
| US9161954B2 | Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment | Human Necessities | 14 | Active |
| US9161956B2 | Amniotic membrane preparations and purified compositions and anti-inflammation methods | Human Necessities | 14 | Active |
| US8455015B2 | Compositions and methods for treating Demodex infestations | Human Necessities | 11 | Active |
| US9682044B2 | Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof | Human Necessities | 9 | Active |
| US9526770B2 | Methods of modulating bone remodeling | Human Necessities | 9 | Active |
| US9175066B2 | Compositions containing HC-HA complex and methods of use thereof | Emerging Cross-Sectional Technologies | 9 | Active |
| US9808491B2 | Compositions of morselized umbilical cord and/or amniotic membrane and methods of use thereof | Human Necessities | 8 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.